Chris Blanchette

Dr. Blanchette has over 20 years of experience in health economics and outcomes research leading teams, departments, and organizations in academia, consulting, and the pharmaceutical industry to plan, evaluate, and communicate clinical, economic, and humanistic outcomes associated with the use of pharmaceuticals and other healthcare interventions using large healthcare data and advanced data science techniques. In his current role, he leads the Clinical Data Science & Evidence department at Novo Nordisk in the US which includes over 80 amazing people who plan, conduct, and synthesize real-world evidence and insights on the use of their products, the healthcare system, and associated patient outcomes.